CSIMarket Company Name, Ticker, Suppliers, else..
 


Biotechnology & Pharmaceuticals Industry Growth Rates

Revenue, Income, Cash Flow and Capital Expenditure Growth Information & Trends 
 


Category:  

 
Biotechnology & Pharmaceuticals Industry 4 Q 3 Q 2 Q 1 Q 4 Q
  FY 2024 2024 2024 2024 FY 2023
Y / Y Revenue Quarterly Growth -2.45 % 13.29 % 12.11 % -1.28 % -1.86 %
Sequential Revenue Quarterly Growth -0.05 % 9.63 % 12.35 % -21 % 14.81 %
Revenue Growth Overall Ranking Y/Y # 80 # 13 # 11 # 62 # 53
Y / Y Revenue Annual Growth (at the end of Fiscal Year) 5.11 % -10.94 %
Y / Y Revenue Growth (12 Months at Quarter Ending) 5.11 % 5.24 % -0.54 % -7.13 % -10.94 %
Sequential Revenue Growth (12 Months at Quarter Ending) -0.69 % 3.16 % 2.74 % -0.36 % 0.55 %
Revenue Growth Ranking Y/Y (TTM) # 43 # 40 # 58 # 81 # 93
Y / Y Operating Income Quarterly Growth 32.66 % 334.8 % 130.55 % - -73.91 %
Sequential Operating Income Quarterly Growth 62.54 % -28.16 % - - 170.71 %
Operating Income Overall Ranking Y/Y # 28 # 5 # 1 # 0 # 90
Y / Y Operating Income Annual Growth (at the end of Fiscal Year) -71.94 % - - -74.76 %
Y / Y Operating Income Growth (12 Months trailing by quarter ending) -71.94 % -92.71 % - - -74.76 %
Sequential Operating Income Growth (12 Months trailing by quarter ending) 46.45 % - - - -47.32 %
Operating Income Growth Ranking Y/Y (TTM) # 91 # 96 # 99 # 99 # 98
Y / Y Income from Cont. Ops Quarterly Growth -83.67 % - - - -78.78 %
Sequential Income from Cont. Ops Quarterly Growth -90.84 % 402.59 % - - -
Income from Cont. Ops Overall Ranking Y/Y # 87 # 0 # 0 # 0 # 87
Y / Y Income from Cont. Ops Annual Growth (at the end of Fiscal Year) - - - - -87.51 %
Y / Y Income from Cont. Ops Growth (12 Months trailing by quarter ending) - - - - -87.51 %
Sequential Income from Cont. Ops Growth (12 Months trailing by quarter ending) - - - - -68.69 %
Income from Cont. Ops Growth Ranking Y/Y (TTM) # 103 # 98 # 100 # 96 # 95
Y / Y Net Income Quarterly Growth -83.5 % - - - -79.09 %
Sequential Net Income Quarterly Growth -90.84 % 402.44 % - - -
Net Income Overall Ranking Y/Y # 82 # 0 # 0 # 0 # 87
Y / Y Net Income Annual Growth (at the end of Fiscal Year) - - - - -87.6 %
Y / Y Net Income Growth (12 Months trailing by quarter ending) - - - - -87.6 %
Sequential Net Income Growth (12 Months trailing by quarter ending) - - - - -68.94 %
Net Income Growth Ranking Y/Y (TTM) # 94 # 97 # 100 # 101 # 94
Y / Y Free Cash Flow Quarterly Growth 252.42 % 169.29 % -45.24 % 2002.95 % -58.2 %
Sequential Free Cash Flow Quarterly Growth 38.03 % 146.21 % 104.88 % -51.62 % 1.25 %
Free Cash Flow Overall Ranking Y/Y # 4 # 5 # 92 # 13 # 91
Y / Y Free Cash Flow Annual Growth (at the end of Fiscal Year) 71.35 % -50.75 %
Y / Y Free Cash Flow Growth (12 Months trailing by quarter ending) 71.35 % 0.15 % -38.43 % -38.12 % -50.75 %
Sequential Free Cash Flow Growth (12 Months trailing by quarter ending) 41.14 % 33.13 % -14.6 % 6.44 % -18.14 %
Free Cash Flow Growth Ranking Y/Y (TTM) # 8 # 59 # 98 # 97 # 101
Y / Y Capital Expenditures Quarterly Growth 34.45 % 3.67 % -22.2 % -8.44 % 10.82 %
Sequential Capital Expenditures Quarterly Growth 54.65 % 5.8 % -7.85 % -11.9 % 17.19 %
Capital Expenditures Overall Ranking Y/Y # 15 # 39 # 90 # 66 # 44
Y / Y Capital Expenditures Annual Growth (at the end of Fiscal Year) 3.5 % 13.42 %
Y / Y Capital Expenditures Growth (12 Months trailing by quarter ending) 3.5 % 5.34 % 7.72 % 14.14 % 13.42 %
Sequential Capital Expenditures Growth (12 Months trailing by quarter ending) 10.94 % 0.35 % -4.77 % -2.33 % 14.2 %
Capital Expenditures Growth Ranking Y/Y (TTM) # 58 # 54 # 58 # 52 # 63

New: More Biotechnology & Pharmaceuticals Industrys' historic Revenue growth >>

Revenue growth Comment
Biotechnology & Pharmaceuticals Industry realized contraction in Revenue by -2.45 % in 4 Q 2024 year on year.

Sequentially Revenue fell by -0.05 %.

Within Healthcare sector 6 other industries have accomplished higher Revenue growth. Revenue decrease overall ranking has deteriorated compared to the previous quarter from 13 to 80.

 

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.



Revenue Y/Y Growth Statistics
High
Average
Low
41.92 % 9.59 % -22.49 %
2. quarter 2021
  
1. quarter 2023

Industry Revenue Y/Y Growth Ranking
Within: No.
Healthcare Sector # 7
Overall Market # 80



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Revenue Y/Y Growth

 


Revenue Y/Y TTM Growth Statistics
High
Average
Low
55.23 % 10.5 % -13.9 %
2. quarter 2021
  
3. quarter 2023

Revenue growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry's pace of Revenue growth in 4 Q 2024 decelerated to 5.11 % year on year, below Biotechnology & Pharmaceuticals Industry average.

Sequentially cumulative Revenue fell by -0.69 %.

Within Healthcare sector 3 other industries have achieved higher Revenue growth. Revenue growth total ranking has declined compared to a quarter before from 40 to 43.

Industry Revenue Y/Y Growth Ranking Annual
Within: No.
Sector # 4
Overall Market # 43

Biotechnology & Pharmaceuticals Industry Operating Income Y/Y Growth

Operating Income growth Comment
Biotechnology & Pharmaceuticals Industry's pace of Operating Income growth in 4 Q 2024 decelerated to 32.66 % year on year, but remained above Industry average.

Sequentially Operating Income grew by 62.54 %.

Within Healthcare sector 3 other industries have accomplished higher Operating Income growth. Operating Income jump overall ranking has deteriorated compared to the previous quarter from 5 to 28.

 



Operating Income Y/Y Growth Statistics
High
Average
Low
334.8 % 18.08 % -83.07 %
3. quarter 2024
  
3. quarter 2019

Industry Operating Income Y/Y Growth Ranking
Within: No.
Healthcare Sector # 4
Overall Market # 28



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Operating Income Y/Y Growth

 


Operating Income Y/Y TTM Growth Statistics
High
Average
Low
137.22 % -5.77 % -111.49 %
2. quarter 2021
  
1. quarter 2024

Operating Income growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry faced contraction in cumulative twelve months Operating Income by -71.94 % in 4 Q 2024 year on year.

Sequentially TTM Operating Income grew by 46.45 %.

Within Healthcare sector 5 other industries have achieved higher Operating Income growth. Operating Income growth total ranking has improved so far to 91, from total ranking in the previous quarter at 96.

Industry Operating Income Y/Y Growth Ranking Annual
Within: No.
Sector # 6
Overall Market # 91

Biotechnology & Pharmaceuticals Industry Income from Cont. Ops Y/Y Growth

Income from Cont. Ops growth Comment
Biotechnology & Pharmaceuticals Industry realized contraction in Income from Cont. Ops by -83.67 % in 4 Q 2024 year on year.

Sequentially Income from Cont. Ops fell by -90.84 %.

Within Healthcare sector 4 other industries have accomplished higher Income from Cont. Ops growth. Income from Cont. Ops decline overall ranking has deteriorated compared to the previous quarter from 0 to 87.

 



Income from Cont. Ops Y/Y Growth Statistics
High
Average
Low
224.83 % 14.85 % -95.85 %
3. quarter 2021
  
3. quarter 2019

Industry Income from Cont. Ops Y/Y Growth Ranking
Within: No.
Healthcare Sector # 5
Overall Market # 87



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Income from Cont. Ops Y/Y Growth

 


Income from Cont. Ops Y/Y TTM Growth Statistics
High
Average
Low
194.97 % -14.73 % -174.36 %
1. quarter 2022
  
4. quarter 2024

Income from Cont. Ops growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry faced contraction in cumulative twelve months Income from Cont. Ops by -182.28 % in 4 Q 2024 year on year.

Sequentially TTM Income from Cont. Ops grew by 143.09 %.

Within Healthcare sector 5 other industries have achieved higher Income from Cont. Ops growth. Income from Cont. Ops growth total ranking has declined compared to a quarter before from 98 to 103.

Industry Income from Cont. Ops Y/Y Growth Ranking Annual
Within: No.
Sector # 6
Overall Market # 103

Biotechnology & Pharmaceuticals Industry Net Income Y/Y Growth

Net Income growth Comment
Biotechnology & Pharmaceuticals Industry realized contraction in Net Income by -83.5 % in 4 Q 2024 year on year.

Sequentially Net Income fell by -90.84 %.

Within Healthcare sector 4 other industries have accomplished higher Net Income growth. Net Income decline overall ranking has deteriorated compared to the previous quarter from 0 to 82.

 



Net Income Y/Y Growth Statistics
High
Average
Low
231.34 % 16.22 % -96.45 %
3. quarter 2021
  
3. quarter 2019

Industry Net Income Y/Y Growth Ranking
Within: No.
Healthcare Sector # 5
Overall Market # 82



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Net Income Y/Y Growth

 


Net Income Y/Y TTM Growth Statistics
High
Average
Low
190.77 % -11.26 % -159.3 %
1
  
2. quarter 2024

Net Income growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry faced contraction in cumulative twelve months Net Income by -182.77 % in 4 Q 2024 year on year.

Sequentially TTM Net Income grew by 138.1 %.

Within Healthcare sector 4 other industries have achieved higher Net Income growth. Net Income growth total ranking has improved so far to 94, from total ranking in the previous quarter at 97.

Industry Net Income Y/Y Growth Ranking Annual
Within: No.
Sector # 5
Overall Market # 94

Biotechnology & Pharmaceuticals Industry Free Cash Flow Y/Y Growth

Free Cash Flow growth Comment
Biotechnology & Pharmaceuticals Industry's pace of Free Cash Flow growth in 4 Q 2024 accelerated to 252.42 % year on year, above Industry average.

Sequentially Free Cash Flow grew by 38.03 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Free Cash Flow growth. Free Cash Flow growth total ranking has improved so far to 4, from total ranking in previous quarter at 5.

 



Free Cash Flow Y/Y Growth Statistics
High
Average
Low
2002.95 % 79.43 % -65.17 %
1. quarter 2024
  
2. quarter 2019

Industry Free Cash Flow Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 4



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Free Cash Flow Y/Y Growth

 


Free Cash Flow Y/Y TTM Growth Statistics
High
Average
Low
88.41 % 7.79 % -50.75 %
1. quarter 2015
  
4. quarter 2023

Free Cash Flow growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry's pace of cumulative 12 months Free Cash Flow growth in 4 Q 2024 accelerated to 71.35 % year on year, above Industry average.

Sequentially TTM Free Cash Flow grew by 41.14 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry accomplished the highest Free Cash Flow growth. Free Cash Flow growth total ranking has improved so far to 8, from total ranking in the previous quarter at 59.

Industry Free Cash Flow Y/Y Growth Ranking Annual
Within: No.
Sector # 1
Overall Market # 8

Biotechnology & Pharmaceuticals Industry Capital Expenditures Y/Y Growth

Capital Expenditures growth Comment
Biotechnology & Pharmaceuticals Industry's pace of Capital Expenditures growth in 4 Q 2024 accelerated to 34.45 % year on year, but remained below Industry average.

Sequentially Capital Expenditures grew by 54.65 %.

Within Healthcare sector, Biotechnology & Pharmaceuticals Industry achieved the highest Capital Expenditures growth. Capital Expenditures growth total ranking has improved so far to 15, from total ranking in previous quarter at 39.

 



Capital Expenditures Y/Y Growth Statistics
High
Average
Low
1737.35 % 91.07 % -87.91 %
1. quarter 2019
  
1. quarter 2018

Industry Capital Expenditures Y/Y Growth Ranking
Within: No.
Healthcare Sector # 1
Overall Market # 15



On the Trailing Twelve Months Basis Biotechnology & Pharmaceuticals Capital Expenditures Y/Y Growth

 


Capital Expenditures Y/Y TTM Growth Statistics
High
Average
Low
88.74 % 11.2 % -55.56 %
3. quarter 2016
  
3. quarter 2020

Capital Expenditures growth Y/Y TTM Comment
On the trailing twelve months basis
Biotechnology & Pharmaceuticals Industry's pace of Capital Expenditures growth in 4 Q 2024 decelerated to 3.5 % year on year, below Biotechnology & Pharmaceuticals Industry average.

Sequentially TTM Capital Expenditures grew by 10.94 %.

Within Healthcare sector 4 other industries have achieved higher Capital Expenditures growth. Capital Expenditures growth total ranking has declined compared to a quarter before from 54 to 58.

Industry Capital Expenditures Y/Y Growth Ranking Annual
Within: No.
Sector # 5
Overall Market # 58





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com